Jane Street
HELP

Jane Street’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Jane Street’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$130K Buy
+19,600
New +$98K ﹤0.01% 10451
2025
Q1 		– Sell
-50,100
Closed -$442K – 9604
2024
Q4 		$442K Buy
+50,100
New +$509K ﹤0.01% 7033

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Jane Street's HELP Position: Q2 2026 in Review

Jane Street increased its Helus Pharma Inc. Common Stock (HELP) stake by 164% in Q2 2026, buying an estimated $873K and bringing the position to 280,903 shares worth $1.86M. The position accounts for ﹤0.01% of the portfolio, ranked #5307.

Jane Street first reported a position in HELP in Q3 2021 and has held it in 17 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Jane Street held 280,903 shares of Helus Pharma Inc. Common Stock worth $1.86M as of Q2 2026.
  • Jane Street bought 174,554 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $873K.
  • Helus Pharma Inc. Common Stock made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5307 holding.
  • Jane Street first reported a position in Helus Pharma Inc. Common Stock in Q3 2021 and has held it in 17 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.